COVID-19 mRNA Vaccine and Antibody Response in Lactating Women: a Prospective Cohort Study

Detalhes bibliográficos
Autor(a) principal: Charepe, N
Data de Publicação: 2021
Outros Autores: Gonçalves, J, Juliano, AM, Lopes, D, Canhão, H, Soares, H, Serrano, F
Tipo de documento: Artigo
Idioma: eng
Título da fonte: Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
Texto Completo: http://hdl.handle.net/10400.17/3856
Resumo: Background: Immunological protection via breastfeeding is well known. The immunological profile of human milk changes during lactation. No clinical trials have been conducted in lactating women with the newest mRNA vaccines against SARS- CoV-2. A Few studies have shown the presence of antibodies in breastmilk after vaccination. The aim of this work is to study possible antibodies transfer via breastmilk and also the immunological characteristics of lactating women compared to non-lactating women, after using the BNT162b2 Pfizer vaccine. Methods: This is a prospective cohort study with a convenience homogenous sample of 24 healthcare workers (14 lactating and 10 non-lactating women) enrolled at the time of COVID-19 vaccination. Clinical data was registered in a questionnaire. Titers of SARS-CoV-2 spike IgG, IgA and IgM were quantified in post vaccination blood and human milk. Antibody quantification was performed by an in-house ELISA to SARS-CoV-2 trimeric spike protein. Results: All women showed immunity after vaccination with positive antibodies for IgM, IgA and IgG antibodies. The dominant serum antibody response was IgG. Modest levels of antibodies in breastmilk of lactating mothers were observed in this study, especially IgG in 42.9%. There was a moderate association between higher titers of IgG and a longer duration of breastfeeding (R= 0.55, p=0.041). Conclusions: Evidence of antibody transfer in human milk after COVID-19 vaccination is scarce. The presence of antibodies in human milk is reported, but immunization through breastfeeding is still to be established.
id RCAP_46014980d097585205e060ed706316b8
oai_identifier_str oai:repositorio.chlc.min-saude.pt:10400.17/3856
network_acronym_str RCAP
network_name_str Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
repository_id_str 7160
spelling COVID-19 mRNA Vaccine and Antibody Response in Lactating Women: a Prospective Cohort StudyMAC GINMAC MED MAFBreastfeedingCovid-19mRNA VaccinationAntibodiesBackground: Immunological protection via breastfeeding is well known. The immunological profile of human milk changes during lactation. No clinical trials have been conducted in lactating women with the newest mRNA vaccines against SARS- CoV-2. A Few studies have shown the presence of antibodies in breastmilk after vaccination. The aim of this work is to study possible antibodies transfer via breastmilk and also the immunological characteristics of lactating women compared to non-lactating women, after using the BNT162b2 Pfizer vaccine. Methods: This is a prospective cohort study with a convenience homogenous sample of 24 healthcare workers (14 lactating and 10 non-lactating women) enrolled at the time of COVID-19 vaccination. Clinical data was registered in a questionnaire. Titers of SARS-CoV-2 spike IgG, IgA and IgM were quantified in post vaccination blood and human milk. Antibody quantification was performed by an in-house ELISA to SARS-CoV-2 trimeric spike protein. Results: All women showed immunity after vaccination with positive antibodies for IgM, IgA and IgG antibodies. The dominant serum antibody response was IgG. Modest levels of antibodies in breastmilk of lactating mothers were observed in this study, especially IgG in 42.9%. There was a moderate association between higher titers of IgG and a longer duration of breastfeeding (R= 0.55, p=0.041). Conclusions: Evidence of antibody transfer in human milk after COVID-19 vaccination is scarce. The presence of antibodies in human milk is reported, but immunization through breastfeeding is still to be established.BioMed CentralRepositório do Centro Hospitalar Universitário de Lisboa Central, EPECharepe, NGonçalves, JJuliano, AMLopes, DCanhão, HSoares, HSerrano, F2021-09-28T15:06:01Z20212021-01-01T00:00:00Zinfo:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/articleapplication/pdfhttp://hdl.handle.net/10400.17/3856engBMC Pregnancy Childbirth. 2021 Sep 17;21(1):632.10.1186/s12884-021-04051-6.info:eu-repo/semantics/openAccessreponame:Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)instname:Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informaçãoinstacron:RCAAP2023-03-10T09:44:28Zoai:repositorio.chlc.min-saude.pt:10400.17/3856Portal AgregadorONGhttps://www.rcaap.pt/oai/openaireopendoar:71602024-03-19T17:21:10.206965Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) - Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informaçãofalse
dc.title.none.fl_str_mv COVID-19 mRNA Vaccine and Antibody Response in Lactating Women: a Prospective Cohort Study
title COVID-19 mRNA Vaccine and Antibody Response in Lactating Women: a Prospective Cohort Study
spellingShingle COVID-19 mRNA Vaccine and Antibody Response in Lactating Women: a Prospective Cohort Study
Charepe, N
MAC GIN
MAC MED MAF
Breastfeeding
Covid-19
mRNA Vaccination
Antibodies
title_short COVID-19 mRNA Vaccine and Antibody Response in Lactating Women: a Prospective Cohort Study
title_full COVID-19 mRNA Vaccine and Antibody Response in Lactating Women: a Prospective Cohort Study
title_fullStr COVID-19 mRNA Vaccine and Antibody Response in Lactating Women: a Prospective Cohort Study
title_full_unstemmed COVID-19 mRNA Vaccine and Antibody Response in Lactating Women: a Prospective Cohort Study
title_sort COVID-19 mRNA Vaccine and Antibody Response in Lactating Women: a Prospective Cohort Study
author Charepe, N
author_facet Charepe, N
Gonçalves, J
Juliano, AM
Lopes, D
Canhão, H
Soares, H
Serrano, F
author_role author
author2 Gonçalves, J
Juliano, AM
Lopes, D
Canhão, H
Soares, H
Serrano, F
author2_role author
author
author
author
author
author
dc.contributor.none.fl_str_mv Repositório do Centro Hospitalar Universitário de Lisboa Central, EPE
dc.contributor.author.fl_str_mv Charepe, N
Gonçalves, J
Juliano, AM
Lopes, D
Canhão, H
Soares, H
Serrano, F
dc.subject.por.fl_str_mv MAC GIN
MAC MED MAF
Breastfeeding
Covid-19
mRNA Vaccination
Antibodies
topic MAC GIN
MAC MED MAF
Breastfeeding
Covid-19
mRNA Vaccination
Antibodies
description Background: Immunological protection via breastfeeding is well known. The immunological profile of human milk changes during lactation. No clinical trials have been conducted in lactating women with the newest mRNA vaccines against SARS- CoV-2. A Few studies have shown the presence of antibodies in breastmilk after vaccination. The aim of this work is to study possible antibodies transfer via breastmilk and also the immunological characteristics of lactating women compared to non-lactating women, after using the BNT162b2 Pfizer vaccine. Methods: This is a prospective cohort study with a convenience homogenous sample of 24 healthcare workers (14 lactating and 10 non-lactating women) enrolled at the time of COVID-19 vaccination. Clinical data was registered in a questionnaire. Titers of SARS-CoV-2 spike IgG, IgA and IgM were quantified in post vaccination blood and human milk. Antibody quantification was performed by an in-house ELISA to SARS-CoV-2 trimeric spike protein. Results: All women showed immunity after vaccination with positive antibodies for IgM, IgA and IgG antibodies. The dominant serum antibody response was IgG. Modest levels of antibodies in breastmilk of lactating mothers were observed in this study, especially IgG in 42.9%. There was a moderate association between higher titers of IgG and a longer duration of breastfeeding (R= 0.55, p=0.041). Conclusions: Evidence of antibody transfer in human milk after COVID-19 vaccination is scarce. The presence of antibodies in human milk is reported, but immunization through breastfeeding is still to be established.
publishDate 2021
dc.date.none.fl_str_mv 2021-09-28T15:06:01Z
2021
2021-01-01T00:00:00Z
dc.type.status.fl_str_mv info:eu-repo/semantics/publishedVersion
dc.type.driver.fl_str_mv info:eu-repo/semantics/article
format article
status_str publishedVersion
dc.identifier.uri.fl_str_mv http://hdl.handle.net/10400.17/3856
url http://hdl.handle.net/10400.17/3856
dc.language.iso.fl_str_mv eng
language eng
dc.relation.none.fl_str_mv BMC Pregnancy Childbirth. 2021 Sep 17;21(1):632.
10.1186/s12884-021-04051-6.
dc.rights.driver.fl_str_mv info:eu-repo/semantics/openAccess
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv application/pdf
dc.publisher.none.fl_str_mv BioMed Central
publisher.none.fl_str_mv BioMed Central
dc.source.none.fl_str_mv reponame:Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
instname:Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação
instacron:RCAAP
instname_str Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação
instacron_str RCAAP
institution RCAAP
reponame_str Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
collection Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
repository.name.fl_str_mv Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) - Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação
repository.mail.fl_str_mv
_version_ 1799131307586879488